Skip to main content

Apellis Pharmaceuticals, Inc.

APLSDelisted May 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001492422

Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of APLS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders2124212+4
Shares91.0M195.2K91.6M+887.5K (+1.0%)
Value$4.62B$9.92M$4.15B−$466.0M (−10.1%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (34)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to APLS in Q2 2022
InstitutionSharesValue% of portfolio
Finepoint Capital LP318,400$14.4M4.98%
Atika Capital Management LLC110,000$4.97M0.65%
Schonfeld Strategic Advisors LLC97,706$4.42M0.05%
Canada Pension Plan Investment Board89,200$4.03M0.01%
AXA S.A.78,305$3.54M0.01%
PDT Partners, LLC60,894$2.75M0.24%
Eaton Vance Management50,424$2.28M0.00%
Ikarian Capital, LLC41,900$1.89M0.79%
Mirae Asset Global Investments Co., Ltd.28,726$1.30M0.00%
Healthcare of Ontario Pension Plan Trust Fund20,300$918.0K0.00%
Panagora Asset Management Inc20,150$911.0K0.01%
Capital Impact Advisors, LLC13,300$601.0K0.56%
Stock Yards Bank & Trust Co13,000$588.0K0.02%
Trexquant Investment LP9,750$441.0K0.02%
Keybank National Association8,373$379.0K0.00%
AQR Capital Management LLC8,307$376.0K0.00%
PEAK6 Investments LLC3,983$362.9K0.01%
Polar Capital Holdings Plc6,900$312.0K0.00%
Delphia (USA) Inc.6,211$281.0K0.19%
Corton Capital Inc.5,606$254.0K0.24%
Campbell & CO Investment Adviser LLC5,527$250.0K0.07%
Dynamic Technology Lab Private Ltd5,370$243.0K0.03%
Boothbay Fund Management, LLC5,065$229.0K0.01%
CWA Asset Management Group, LLC5,000$226.0K0.02%
Xponance, Inc.4,885$221.0K0.00%
Quintet Private Bank (Europe) S.A.765$68.2K0.00%
SG3 Management, LLC1,155$52.0K0.10%
CoreCap Advisors, LLC300$14.0K0.00%
Baillie Gifford & Co283$13.0K0.00%
State of Wyoming150$7.00K0.00%
Quadrant Capital Group LLC84$4.00K0.00%
Bell Investment Advisors, Inc50$2.00K0.00%
Capital Advisors, Ltd. LLC8$00.00%
Harvest Group Wealth Management, LLC8$00.00%

Sold out (30)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (4)

Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding APLS in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Teachers Retirement System of the State of Kentucky144,468$7.34M
Parametric Portfolio Associates LLC32,298$1.64M
Amalgamated Financial Corp.12,464$633.0K
Virginia Retirement Systems Et Al6,000$305.0K